GOSSAMER BIO, INC. Capital Expenditures
GOSSAMER BIO, INC. (GOSS) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- GOSSAMER BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- GOSSAMER BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- GOSSAMER BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00.
- GOSSAMER BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- GOSSAMER BIO, INC. payments to acquire property, plant, and equipment for fiscal 2025 was $79.00K.
- GOSSAMER BIO, INC. payments to acquire property, plant, and equipment for fiscal 2024 was $0.00.
- GOSSAMER BIO, INC. payments to acquire property, plant, and equipment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- GOSSAMER BIO, INC. payments to acquire property, plant, and equipment for fiscal 2022 was $410.00K, a 73.48% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | $53.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $53.00K derived: sum of 3 quarters · filed 2026-08-13 | $79.00K 10-K · filed 2026-03-17 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $53.00K derived: sum of 2 quarters · filed 2026-08-13 | $79.00K 10-Q · filed 2025-11-05 | $79.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $53.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $79.00K 10-Q · filed 2026-08-13 | $79.00K derived: sum of 3 quarters · filed 2026-08-13 | $79.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $26.00K 10-Q · filed 2026-05-15 | $26.00K derived: sum of 2 quarters · filed 2026-05-15 | $26.00K derived: sum of 3 quarters · filed 2026-05-15 | $26.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $0.00 derived: sum of 3 quarters · filed 2026-03-17 | $0.00 10-K · filed 2026-03-17 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-17 | $0.00 derived: sum of 4 quarters · filed 2026-03-17 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $0.00 derived: sum of 3 quarters · filed 2026-03-17 | $0.00 derived: sum of 4 quarters · filed 2026-03-17 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | $0.00 derived: sum of 3 quarters · filed 2026-03-17 | $0.00 10-K · filed 2026-03-17 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $102.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $0.00 10-Q · filed 2023-08-08 | $102.00K derived: sum of 3 quarters · filed 2025-03-13 | $133.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $102.00K derived: sum of 2 quarters · filed 2025-03-13 | $133.00K derived: sum of 3 quarters · filed 2025-03-13 | $253.00K derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $133.00K derived: sum of 2 quarters · filed 2025-03-13 | $253.00K derived: sum of 3 quarters · filed 2025-03-13 | $410.00K 10-K · filed 2025-03-13 |
| 2022-09-30 | $31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $151.00K derived: sum of 2 quarters · filed 2023-11-09 | $308.00K 10-Q · filed 2023-11-09 | $391.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-06-30 | $120.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $277.00K 10-Q · filed 2023-08-08 | $360.00K derived: sum of 3 quarters · filed 2024-03-05 | $883.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-03-31 | $157.00K 10-Q · filed 2023-05-09 | $240.00K derived: sum of 2 quarters · filed 2024-03-05 | $763.00K derived: sum of 3 quarters · filed 2024-03-05 | $901.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2021-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $606.00K derived: sum of 2 quarters · filed 2024-03-05 | $744.00K derived: sum of 3 quarters · filed 2024-03-05 | $1.55M 10-K · filed 2024-03-05 |
| 2021-09-30 | $523.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $661.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.46M 10-Q · filed 2022-11-03 | $1.71M derived: sum of 4 quarters · filed 2023-03-17 |
| 2021-06-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $940.00K 10-Q · filed 2022-08-09 | $1.19M derived: sum of 3 quarters · filed 2023-03-17 | $1.49M derived: sum of 4 quarters · filed 2023-03-17 |
| 2021-03-31 | $802.00K 10-Q · filed 2022-05-10 | $1.05M derived: sum of 2 quarters · filed 2023-03-17 | $1.35M derived: sum of 3 quarters · filed 2023-03-17 | $1.79M derived: sum of 4 quarters · filed 2023-03-17 |
| 2020-12-31 | $250.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $549.00K derived: sum of 2 quarters · filed 2023-03-17 | $990.00K derived: sum of 3 quarters · filed 2023-03-17 | $1.50M 10-K · filed 2023-03-17 |
| 2020-09-30 | $299.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $740.00K derived: sum of 2 quarters · filed 2021-11-08 | $1.25M 10-Q · filed 2021-11-08 | $1.78M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-06-30 | $441.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $954.00K 10-Q · filed 2021-08-09 | $1.48M derived: sum of 3 quarters · filed 2022-03-03 | $2.19M derived: sum of 4 quarters · filed 2022-03-03 |
| 2020-03-31 | $513.00K 10-Q · filed 2021-05-06 | $1.04M derived: sum of 2 quarters · filed 2022-03-03 | $1.75M derived: sum of 3 quarters · filed 2022-03-03 | $3.13M derived: sum of 4 quarters · filed 2022-03-03 |
| 2019-12-31 | $528.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.24M derived: sum of 2 quarters · filed 2022-03-03 | $2.62M derived: sum of 3 quarters · filed 2022-03-03 | $2.97M 10-K · filed 2022-03-03 |
| 2019-09-30 | $711.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $2.09M derived: sum of 2 quarters · filed 2020-11-10 | $2.44M 10-Q · filed 2020-11-10 | $2.76M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $1.73M 10-Q · filed 2020-08-11 | $2.05M derived: sum of 3 quarters · filed 2021-02-26 | $3.77M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $347.00K 10-Q · filed 2020-05-12 | $669.00K derived: sum of 2 quarters · filed 2021-02-26 | $2.38M derived: sum of 3 quarters · filed 2021-02-26 | $3.33M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $322.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $2.04M derived: sum of 2 quarters · filed 2021-02-26 | $2.98M derived: sum of 3 quarters · filed 2021-02-26 | $3.49M 10-K · filed 2021-02-26 |
| 2018-09-30 | $1.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $2.66M derived: sum of 2 quarters · filed 2019-11-12 | $3.17M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $941.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $1.45M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $511.00K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 |